FY25 Key Financial Results and Annual Report
Summary
Starpharma (ASX: SPL, OTCQX: SPHRY), an innovative biotechnology company with two decades of experience in advancing dendrimer technology from the lab to the patient, today releases its annual report and full-year financial results for the year ended 30 June 2025.
Your question will be sent privately to Starpharma. The company may choose to make this question public.
Start the conversation
Ask Starpharma a question about this announcement.
Share your feedback
Discover